key: cord-0743975-tplpxvgg
authors: Luo, Liman; Fu, Menglu; Li, Yuanyuan; Hu, Shuiqing; Luo, Jinlan; Chen, Zhihui; Yu, Jing; Li, Wenhua; Dong, Ruolan; Yang, Yan; Tu, Ling; Xu, Xizhen
title: The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis
date: 2020-10-07
journal: Clin Cardiol
DOI: 10.1002/clc.23465
sha: c158018285ed351ceb70388552daf64cc56cbed7
doc_id: 743975
cord_uid: tplpxvgg

BACKGROUD: The association between underlying comorbidities and cardiac injury and the prognosis in coronavirus disease 2019 (COVID‐19) patients was assessed in this study. HYPOTHESIS: The underlying comorbidities and cardiac injury may be associated with the prognosis in COVID‐19 patients. METHODS: A systematic search was conducted in PubMed, EMBASE, Web of science, and The Cochrane library from December 2019 to July 2020. The odds ratio (OR) and 95% confidence intervals (95% CI) were used to estimate the probability of comorbidities and cardiac injury in COVID‐19 patients with or without severe type, or in survivors vs nonsurvivors of COVID‐19 patients. RESULTS: A total of 124 studies were included in this analysis. A higher risk for severity was observed in COVID‐19 patients with comorbidities. The pooled result in patients with hypertension (OR 2.57, 95% CI: 2.12‐3.11), diabetes (OR 2.54, 95% CI: 1.89‐3.41), cardiovascular diseases (OR 3.86, 95% CI: 2.70‐5.52), chronic obstractive pulmonary disease (OR 2.71, 95% CI: 1.98‐3.70), chronic kidney disease (OR 2.20, 95% CI: 1.27‐3.80), and cancer (OR 2.42, 95% CI: 1.81‐3.22) respectively. All the comorbidities presented a higher risk of mortality. Moreover, the prevalence of acute cardiac injury is higher in severe group than in nonsevere group, and acute cardiac injury is associated with an increased risk for in‐hospital mortality. CONCLUSION: Comorbidities and acute cardiac injury are closely associated with poor prognosis in COVID‐19 patients. It is necessary to continuously monitor related clinical indicators of organs injury and concern comorbidities in COVID‐19 patients.

Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic and a public health event of widespread concern. 1-5 To date, more than 3.4 million individuals worldwide with confirmed COVID- 19 , of whom more than 200 000 have lost their lives. The higher incidence of comorbidities in COVID-19 patients, including hypertension, diabetes and cardiovascular disease et al, was reported in recent retrospective studies. Cardiovascular metabolic comorbidities may be a risk factor for poor prognosis. In addition, COVID-19 patients have different degrees of myocardial damage in addition to respiratory symptoms, especially in critically ill patients.

Huang et al. 6 first reported that 32% of the cases had comorbidities, 8% developed myocardial injury, and the mortality rate as high as 15% in 41 confirmed patients. The study of Yang et al. 7 indicated that elderly critically ill patients (> 65 years old) with comorbidities and acute respiratory distress syndrome (ARDS) are at higher risk of death. In addition, Guo T et al 8 and Shi et al. 9 reported that COVID-19 patients with myocardial injury had a significantly higher mortality rate than patients without myocardial injury. Given the worldwide pandemic of this infectious disease, it is necessary to identify the risk factors associated with increased risk of in-hospital mortality in COVID-19 patients. Although, some clinical case series studies demonstrated that comorbidities including hypertension, diabetes, and cardiovascular diseases (CVD), chronic obstractive pulmonary disease (COPD), chronic kidney disease (CKD), and cancer may be predictors for the poor prognosis in COVID-19 patients, the number of enrolled patients was limited, and potential confounding factors were not excluded, so it still needs to be further confirmed. In this study, we conducted a systematic review of available studies to assess the association between underlying comorbidities and acute cardiac injury and the severity or the prognosis in COVID-19 patients.

We conducted systematic retrieval in PubMed, EMBASE (by Ovidsp), Web of Science and The Cochrane Library from December 2019 to July 2020. The free keywords included "comorbidities", "hypertension", "diabetes", "cardiovascular disease", "cardiac injury", "chronic obstractive pulmonary disease", "chronic kidney disease", "cancer", "novel coronavirus pneumonia", "COVID-19", "2019-nCoV" and "clinical characteristics".

Additionally, we checked the references of each cited manuscript to identify other possibly eligible studies. This pooled analysis was conducted and reported in compliance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. 10 Eligible studies should be written in English, and describe the relationship between age, gender, comorbidities and the prognosis of adult COVID-19 patients. The number of enrolled patients is more than ten. Case reports, reviews, letters, family-based studies, nonhuman studies, studies without adequate information, studies written not in English, studies focused only on children or pregnant women, and patients not stratified with the degree of severity or survivors were excluded. The inclusion of each study was determined by two researchers. Disagreements were resolved through a consensus. 

Two reviewers independently extracted data from the included studies. Discrepancies were resolved by consensus between the two reviewers. Variables included authors, sample size, age, gender, relevant data on comorbidity of severe and nonsevere, and of survivors and nonsurvivors (including hypertension, diabetes, CVD, COPD, CKD, and cardiac injury). Cardiac injury was defined by elevation of Troponin I/T. The New castle Ottawa scale (NOS) was followed to assess the quality of studies. 11 The primary outcome was to explore the association between the comorbidities or acute cardiac injury and severity or mortality in confirmed COVID-19 patients.

The association of comorbidities (hypertension, diabetes, and cardiovascular diseases(CVD), chronic obstractive pulmonary disease(COPD), chronic kidney disease(CKD), and cancer)with COVID-19 severity

Pooled analysis was performed using STATA software (version 14.0).

The odds ratio (OR) and 95% confidence intervals (95% CI) were used to estimate the probability of comorbidities or cardiac injury in COVID-19 patients with or without severe type, or in survivors vs nonsurvivors of COVID-19 patients. Magnitude of heterogeneity was calculated using the I 2 statistic: 25%, 50%, and 75% representing low, medium, and high heterogeneity, respectively. Due to the heterogeneity between studies, a random effect model was performed to estimating the average effect. 12 In order to assess the impact of age (mean age or median age) and sex (percentage of males), univariable meta-regression models were performed. Publication bias was evaluated by the Bgger's test, with P > .05 indicated no evidence of publication bias. 13

Initial database search identified 6196 studies and 34 additional records through reference and citation searches ( Figure 1 ). Overall, 329 of them with full-text were reviewed for eligibility, of which 124 studies were included in this analysis. [7] [8] [9] The NOS scores ranged between 5 and 8. The key characteristics of included studies were presented in Table S1 . The majority of included studies were based in Asia, the minority was from the USA, Italy, Spain and other countries. With most studies including more males than females, and the mean age varied from a median of 40 to 84 years of age. 58 studies compared the incidence of hypertension or diabetes in severe vs nonsevere cases with COVID-19 and 29 studies compared the prevalence of CVD. Eleven studies reported the association between acute cardiac injury and the severity of COVID-19. Sixty three documents reported the incidence of cardiovascular metabolic diseases in nonsurvivors vs survivors.

The association between comorbidities and disease severity were presented in Figure 2 Figure 3 , Table S2 ). Moreover, it is observed that the prevalence of acute cardiac injury is higher in severe group than in nonsevere group (OR:6.57; 95% CI 3.70-11.65), and acute cardiac injury is associated with an increased risk for mortality (OR:16.96; 95% CI 7.89-36.44) (Figure 4) .

The results of univariable meta-regression analyses showed the impact of age and sex on the association between comorbidities or acute cardiac injury and the prognosis (severity and mortality) in COVID-19 patients. There was a clearer effect of increasing age on the association between hypertesion and diabetes and severity of COVID-19 (sFig1, sFig2). Conversely, there is no significant association between the proportion of males with the risk of severity or mortality. No obvious evidence of publication bias existed (Table S2) . This pooled analysis is based on data from 124 studies with confirmed COVID-19. In this study, it is observed that the comorbidities makes COVID-19 patients more likely to develop severe clinical type and increase the risk for in-hospital death. Comorbidities may be a risk factor for critically ill patients with poor prognosis. Another important finding is that acute cardiac injury increased the risk of severity and

in-hospital death for patients with COVID-19. According to the current research data, some patients with COVID-19 suffered acute cardiac injury, and the incidence of acute cardiac injury is much higher in severe cases. 6, 21, 24 However, the pathogenesis of acute cardiac injury associated with COVID-19 is still needs further investigation. The unique and significant affinity of SARS-CoV-2 for the host ACE2 receptor increases the possibility of direct infection of vascular endothelium and myocardium. Meanwhile, hypoxemia and cytokine storm may also be an important cause of acute cardiac injury. 6 Therefore, it is necessary to monitor acute cardiac injury markers and cardiac function during hospitalization, and pay more attention to heart damage related to SARS-CoV-2 infection in the course of disease treatment, and take more active treatment for patients with acute cardiac injury.

A recent study on influenza showed that patients with cardiovascular disease and hypertension have a higher risk of death than those without comorbidities. 138 

Comorbidities and acute cardiac injury are closely associated with poor prognosis in COVID-19 patients. It is necessary to continuously monitor related clinical indicators of organs injury and concern comorbidities in COVID-19 patients.

The authors declare they have no conflict of interest.

The data supporting this systematic review are from previously reported studies and datasets, which have been cited. 

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -the latest 2019 novel coronavirus outbreak in Wuhan

Outbreakof pneumonia of unknown etiology in Wuhan China: the mystery and the miracle

Report of novel coronavirusinfected pneumonia in China

Coronavirus infections-more than just the common cold

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report -66. World Health Organization

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)

Associationof cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Preferred reporting items for system-atic review and meta-analyses of individual participant data: the PRISMA-IPD statement

Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in lowincome and middleincome countries: a systematic review and metaanalysis

Meta-analysis in clinical trials

Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

Clinical features and treatment of COVID-19 patients in Northeast Chongqing

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): first report from the United States

Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes

Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single Centre study

Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait

Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain

Predictors for severe COVID-19 infection

A cohort of patients with COVID-19 in a major teaching hospital in Europe

Clinical features and outcomes of 105 hospitalized patients with COVID-19 in

COVID-19 in a designated infectious diseases hospital outside Hubei Province

Clinical features and short-term outcomes of 102 patients with Corona virus disease 2019 in Wuhan

Clinical characteristics of coronavirus disease 2019 patients in Beijing

Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-Centre observational study

Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China

The characteristics and outcomes of 681 severe cases with COVID-19 in China

Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19

Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a Nationwide analysis in China

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study

Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study. medRxiv

Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients

Predictors of mortality in adults admitted with COVID-19: retrospective cohort Study from New York City

Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from northern Italy

Early predictors of clinical outcomes of COVID-19 outbreak in Milan

Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia

Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years

Clinical determinants for fatality of 44,672 patients with COVID-19

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) in Bolivia: an analysis of the first 107 confirmed cases

Cardiac injuries in patients with coronavirus disease 2019: not to be ignored

COVID-19 with different severity: a multi-center study of clinical features

Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19

Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York

Characteristics, outcomes and indicators of severity for COVID-19 among sample of ESNA quarantine Hospital's patients, Egypt: a retrospective study

Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy

Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care Centre in Switzerland: an observational analysis

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Diabetes is a risk factor for the progression and prognosis of COVID-19

Factors associated with death in critically ill patients with coronavirus disease 2019 in the US

Demographic and clinical features of critically ill patients with COVID-19 in Greece: the burden of diabetes and obesity

Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China

Comparing rapid scoring Systems in Mortality Prediction of critically ill patients with novel coronavirus disease

Predictors of coronavirus disease 2019 severity: a retrospective study of 64 cases

Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study

COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study

Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in northern Italy

Clinical characterization of 162 COVID-19 patients in Israel: preliminary report from a large tertiary center

Prognostic factors for severe coronavirus disease 2019 in Daegu

Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol north of Iran: a retrospective cohort study

Effect of underlying comorbidities on the infection and severity of COVID-19 in Korea: a Nationwide casecontrol study

Characteristics and outcomes of COVID-19 patients in New York City's public hospital system. medRxiv

The clinical characteristics and outcomes of patients with moderate-to-severe coronavirus disease 2019 infection and diabetes in Daegu, South Korea

Epidemiological and clinical characteristics of coronavirus disease 2019 in Daegu, South Korea

Risk factors for mortality and respiratory support in elderly patients hospitalized with COVID-19 in Korea

Association of reninangiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China

Defining heart disease risk for death in COVID-19 infection

Clinical characteristics and outcomes of 74 patients with severe or critical COVID-19

Radiographic findings and other predictors in adults with Covid-19

The clinical and chest CT features associated with severe and critical COVID-19 pneumonia

Clinical characteristics of SARS-CoV-2 infections involving 325 hospitalized patients outside Wuhan

Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China

Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study

Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage

Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing

Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study

COVID-19 myocarditis and severity factors: an adult cohort study. medRxiv

Neurologic manifestations of hospitalized patients with coronavirus disease

Cardiovascular disease, drug therapy, and mortality in Covid-19

Risk factors for mortality in patients with COVID-19 in New York City

Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland

Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a casecontrol study

Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area -a retrospective cohort study

Dysregulation of immune response in patients with COVID-19 in Wuhan

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan

Model-based prediction of critical illness in hospitalized patients with COVID-19. Radiology

Demographics, comorbidities and outcomes in hospitalized Covid-19 patients in rural Southwest Georgia

Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the south of Iran

Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019

Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan

Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study

Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the diamond princess cruise ship: a retrospective analysis

Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study

Epidemiological and clinical course of 483 patients with COVID-19 in Wuhan, China: a single-center, retrospective study from the mobile cabin hospital

Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan

15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study

Clinical and laboratory predictors of inhospital mortality in patients with COVID-19: a cohort study in Wuhan, China

Clinical characteristics and outcomes of 421 patients with coronavirus disease 2019 treated in a mobile cabin hospital

Clinical course and outcomes of 344 intensive care patients with COVID-19

Clinical characteristics of patients with severe pneumonia caused by the SARS-CoV-2 in Wuhan

Clinical characteristics of patients infected with the novel 2019 coronavirus (SARS-Cov-2) in Guangzhou, China. Open Forum Infect Dis

Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis

Clinical characteristics of 276 hospitalized patients with coronavirus disease

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study

Impact of cardiovascular disease on clinical characteristics and outcomes of coronavirus disease 2019 (COVID-19)

Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan

Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study

Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019

Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients

Impact of comorbidities on patients with COVID-19: a large retrospective study in Zhejiang

Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience

Clinical characteristics, associated factors, and predicting COVID-19 mortality risk: a retrospective study in Wuhan, China

Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai

Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China

Myocardial injury is associated with inhospitalmortality of confirmed or suspected COVID-19 in Wuhan, China: a single center retrospective cohort study. medRxiv

Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. medRxiv

Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China

Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study

Association of diabetes mellitus with disease severity and prognosis in COVID-19: a retrospective cohort study

A retrospective analysis of the clinical and epidemiological characteristics of COVID-19 patients in Henan provincial People's hospital

Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study

Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province

Association of blood glucose control and outcomes in patients with covid-19 and pre-existing type 2 diabetes

Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019

Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy

Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions

Systemic inflammatory response syndrome

Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis

Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia

Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis

Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: a meta-regression and decision tree analysis

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a metaanalysis of observational studies

The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis

The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis